Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncolytic Virotherapy | 58 | 2024 | 515 | 8.840 |
Why?
|
Simplexvirus | 68 | 2024 | 803 | 8.350 |
Why?
|
Oncolytic Viruses | 39 | 2024 | 343 | 5.150 |
Why?
|
Glioblastoma | 39 | 2024 | 3482 | 3.450 |
Why?
|
Genetic Vectors | 54 | 2024 | 3378 | 2.820 |
Why?
|
Herpesvirus 1, Human | 36 | 2024 | 753 | 2.380 |
Why?
|
Virus Replication | 43 | 2024 | 2431 | 1.920 |
Why?
|
Brain Neoplasms | 42 | 2024 | 8984 | 1.900 |
Why?
|
Interleukin-12 | 10 | 2018 | 584 | 1.890 |
Why?
|
Neoplastic Stem Cells | 18 | 2019 | 1347 | 1.770 |
Why?
|
Immunotherapy | 15 | 2024 | 4637 | 1.590 |
Why?
|
Herpes Simplex | 10 | 2024 | 477 | 0.980 |
Why?
|
Viral Proteins | 5 | 2018 | 1802 | 0.680 |
Why?
|
Tumor Cells, Cultured | 28 | 2019 | 6131 | 0.650 |
Why?
|
Mice, Nude | 33 | 2015 | 3605 | 0.620 |
Why?
|
Gene Deletion | 4 | 2018 | 2668 | 0.610 |
Why?
|
Nerve Sheath Neoplasms | 4 | 2014 | 167 | 0.610 |
Why?
|
Tumor Microenvironment | 11 | 2024 | 3826 | 0.590 |
Why?
|
Animals | 120 | 2024 | 167940 | 0.580 |
Why?
|
Neoplasms | 12 | 2024 | 22066 | 0.570 |
Why?
|
Vero Cells | 18 | 2021 | 484 | 0.570 |
Why?
|
DNA, Viral | 13 | 2017 | 2195 | 0.550 |
Why?
|
Biological Products | 4 | 2021 | 914 | 0.540 |
Why?
|
Rad51 Recombinase | 1 | 2017 | 188 | 0.540 |
Why?
|
Mice | 83 | 2024 | 81216 | 0.520 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 656 | 0.520 |
Why?
|
Disease Models, Animal | 21 | 2020 | 18134 | 0.500 |
Why?
|
Xenograft Model Antitumor Assays | 19 | 2020 | 3584 | 0.480 |
Why?
|
Phthalazines | 1 | 2017 | 377 | 0.470 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1090 | 0.450 |
Why?
|
Macrophages | 5 | 2018 | 5745 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 995 | 0.450 |
Why?
|
Defective Viruses | 10 | 2000 | 89 | 0.420 |
Why?
|
Meningioma | 6 | 2023 | 1220 | 0.420 |
Why?
|
Immune Evasion | 1 | 2016 | 362 | 0.420 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2005 | 501 | 0.400 |
Why?
|
Immunohistochemistry | 8 | 2020 | 11064 | 0.400 |
Why?
|
Neoplasm Transplantation | 20 | 2017 | 2014 | 0.390 |
Why?
|
Vaccination | 2 | 2021 | 3360 | 0.390 |
Why?
|
Adaptive Immunity | 1 | 2016 | 724 | 0.380 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9196 | 0.370 |
Why?
|
DNA Replication | 14 | 2017 | 1412 | 0.360 |
Why?
|
Pseudorabies | 2 | 2000 | 6 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4554 | 0.350 |
Why?
|
Cancer Vaccines | 6 | 2014 | 1044 | 0.340 |
Why?
|
Neurogenic Inflammation | 2 | 2000 | 33 | 0.340 |
Why?
|
Neoplasms, Experimental | 8 | 2008 | 1229 | 0.330 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2018 | 4355 | 0.330 |
Why?
|
Cell Line, Tumor | 32 | 2020 | 16905 | 0.330 |
Why?
|
Cystitis | 2 | 2000 | 96 | 0.330 |
Why?
|
Meningeal Neoplasms | 5 | 2023 | 1248 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5230 | 0.320 |
Why?
|
Neural Cell Adhesion Molecules | 2 | 2000 | 121 | 0.310 |
Why?
|
Gene Transfer Techniques | 11 | 2012 | 1204 | 0.310 |
Why?
|
Antineoplastic Agents, Alkylating | 4 | 2020 | 619 | 0.310 |
Why?
|
Transgenes | 6 | 2021 | 1006 | 0.300 |
Why?
|
Glutamate Decarboxylase | 2 | 1998 | 239 | 0.300 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1447 | 0.300 |
Why?
|
Immunity, Innate | 2 | 2016 | 3046 | 0.280 |
Why?
|
Mice, Inbred BALB C | 23 | 2015 | 6226 | 0.270 |
Why?
|
Recombinases | 1 | 2006 | 66 | 0.270 |
Why?
|
Piperazines | 1 | 2017 | 2520 | 0.270 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2006 | 191 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 2449 | 0.260 |
Why?
|
Glioma | 10 | 2019 | 3420 | 0.260 |
Why?
|
Antineoplastic Agents | 10 | 2013 | 13629 | 0.260 |
Why?
|
Mice, SCID | 5 | 2019 | 2627 | 0.250 |
Why?
|
Cytotoxicity, Immunologic | 6 | 2018 | 1351 | 0.240 |
Why?
|
Angiogenesis Inhibitors | 6 | 2014 | 2047 | 0.240 |
Why?
|
gamma-Aminobutyric Acid | 3 | 2003 | 1132 | 0.240 |
Why?
|
Ganciclovir | 4 | 2001 | 252 | 0.230 |
Why?
|
Combined Modality Therapy | 14 | 2018 | 8551 | 0.230 |
Why?
|
Mice, Inbred C57BL | 17 | 2018 | 22025 | 0.230 |
Why?
|
Humans | 98 | 2024 | 760261 | 0.210 |
Why?
|
Astrocytes | 4 | 2013 | 1335 | 0.210 |
Why?
|
Injections, Intralesional | 6 | 2014 | 278 | 0.210 |
Why?
|
Angiostatins | 2 | 2013 | 64 | 0.210 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1262 | 0.190 |
Why?
|
Thymidine Kinase | 3 | 2001 | 286 | 0.190 |
Why?
|
Promoter Regions, Genetic | 7 | 2019 | 5784 | 0.190 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 886 | 0.190 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 3726 | 0.190 |
Why?
|
Bone Marrow Purging | 1 | 2001 | 108 | 0.190 |
Why?
|
Dacarbazine | 3 | 2011 | 560 | 0.180 |
Why?
|
DNA-Directed DNA Polymerase | 11 | 1990 | 491 | 0.180 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2020 | 135 | 0.180 |
Why?
|
T-Phages | 5 | 1990 | 90 | 0.180 |
Why?
|
Signal Transduction | 7 | 2018 | 23363 | 0.180 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2000 | 40 | 0.180 |
Why?
|
Cytopathogenic Effect, Viral | 8 | 2012 | 151 | 0.170 |
Why?
|
Cell Degranulation | 1 | 2000 | 278 | 0.170 |
Why?
|
Central Nervous System | 3 | 1996 | 1334 | 0.160 |
Why?
|
DNA Repair | 7 | 2017 | 2039 | 0.160 |
Why?
|
Neuroblastoma | 7 | 2009 | 1252 | 0.160 |
Why?
|
Herpesvirus 1, Suid | 1 | 1998 | 25 | 0.160 |
Why?
|
Neurites | 2 | 2000 | 389 | 0.160 |
Why?
|
Central Nervous System Neoplasms | 2 | 2023 | 917 | 0.160 |
Why?
|
Recombinant Proteins | 3 | 2006 | 6543 | 0.150 |
Why?
|
Mice, Inbred A | 3 | 2011 | 246 | 0.150 |
Why?
|
Liver Neoplasms, Experimental | 1 | 1999 | 190 | 0.150 |
Why?
|
Pericytes | 1 | 2020 | 292 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2007 | 2866 | 0.150 |
Why?
|
Apoptosis | 9 | 2017 | 9497 | 0.150 |
Why?
|
Transfection | 7 | 2006 | 5782 | 0.150 |
Why?
|
Prostatic Neoplasms | 11 | 2012 | 11341 | 0.150 |
Why?
|
Tumor Stem Cell Assay | 1 | 2017 | 115 | 0.140 |
Why?
|
Adenocarcinoma | 6 | 2009 | 6310 | 0.140 |
Why?
|
Melanoma, Experimental | 1 | 2000 | 562 | 0.140 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 666 | 0.140 |
Why?
|
Urinary Bladder | 2 | 2000 | 1166 | 0.140 |
Why?
|
Endopeptidases | 1 | 2020 | 772 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 642 | 0.130 |
Why?
|
Cell Division | 5 | 2001 | 4462 | 0.130 |
Why?
|
Mutation | 18 | 2012 | 29950 | 0.120 |
Why?
|
Cell Survival | 5 | 2017 | 5796 | 0.120 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 428 | 0.120 |
Why?
|
Antigens, Surface | 1 | 2019 | 1616 | 0.120 |
Why?
|
Cerebellum | 2 | 2000 | 1495 | 0.120 |
Why?
|
2-Acetylaminofluorene | 6 | 1986 | 10 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2017 | 553 | 0.120 |
Why?
|
Cell Proliferation | 7 | 2019 | 10434 | 0.120 |
Why?
|
Melanoma | 3 | 2024 | 5695 | 0.110 |
Why?
|
Transplantation, Heterologous | 6 | 2011 | 2378 | 0.110 |
Why?
|
Membrane Proteins | 2 | 2020 | 7854 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2424 | 0.110 |
Why?
|
Blotting, Western | 4 | 2017 | 5039 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5640 | 0.110 |
Why?
|
Mast Cells | 1 | 2000 | 1428 | 0.110 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 373 | 0.110 |
Why?
|
Interleukin-2 | 3 | 2024 | 1890 | 0.110 |
Why?
|
Cisplatin | 1 | 1999 | 1642 | 0.110 |
Why?
|
Female | 42 | 2020 | 391011 | 0.110 |
Why?
|
Neovascularization, Pathologic | 5 | 2018 | 2641 | 0.110 |
Why?
|
Breast Neoplasms | 6 | 2019 | 21065 | 0.110 |
Why?
|
Antiviral Agents | 3 | 2001 | 3061 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 302 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1558 | 0.100 |
Why?
|
Cytokines | 2 | 2024 | 7345 | 0.100 |
Why?
|
Cell Culture Techniques | 2 | 2018 | 1663 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3735 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9274 | 0.100 |
Why?
|
Gene Order | 1 | 2012 | 169 | 0.100 |
Why?
|
DNA Polymerase I | 8 | 1986 | 43 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1999 | 0.100 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2012 | 625 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3731 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2006 | 2297 | 0.100 |
Why?
|
Nucleoproteins | 1 | 1991 | 113 | 0.100 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 620 | 0.100 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2012 | 122 | 0.090 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 74 | 0.090 |
Why?
|
Vinblastine | 1 | 2012 | 487 | 0.090 |
Why?
|
Neurilemmoma | 2 | 2007 | 523 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2012 | 180 | 0.090 |
Why?
|
Cell Cycle Proteins | 3 | 2019 | 3448 | 0.090 |
Why?
|
Cell Cycle | 2 | 2017 | 2937 | 0.090 |
Why?
|
Dilazep | 1 | 2010 | 4 | 0.090 |
Why?
|
Organ Culture Techniques | 2 | 2010 | 796 | 0.090 |
Why?
|
Rats | 13 | 2011 | 23695 | 0.090 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1137 | 0.090 |
Why?
|
RNA-Binding Proteins | 2 | 2018 | 1892 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 7 | 2003 | 8157 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3804 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Etoposide | 1 | 2011 | 630 | 0.090 |
Why?
|
Transcription, Genetic | 4 | 2006 | 7593 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 547 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1956 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 2001 | 4546 | 0.080 |
Why?
|
Adenoviridae | 2 | 2020 | 1084 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2013 | 718 | 0.080 |
Why?
|
Neoplasm Invasiveness | 3 | 2012 | 3618 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 496 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2013 | 5873 | 0.080 |
Why?
|
Denervation | 2 | 2000 | 277 | 0.080 |
Why?
|
Blood-Brain Barrier | 2 | 2005 | 1017 | 0.080 |
Why?
|
Imidazoles | 1 | 2014 | 1178 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3217 | 0.080 |
Why?
|
Peroxidase | 1 | 2011 | 604 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3443 | 0.070 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2010 | 459 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5498 | 0.070 |
Why?
|
Ribonucleotide Reductases | 4 | 2010 | 76 | 0.070 |
Why?
|
Mice, Inbred Strains | 3 | 2007 | 1765 | 0.070 |
Why?
|
Survival Analysis | 4 | 2018 | 10185 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2805 | 0.070 |
Why?
|
HeLa Cells | 3 | 2008 | 3105 | 0.070 |
Why?
|
Gene Expression | 5 | 2000 | 7592 | 0.070 |
Why?
|
Edema | 1 | 2011 | 772 | 0.070 |
Why?
|
Protein Binding | 1 | 2019 | 9336 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4312 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 1135 | 0.070 |
Why?
|
Pyrimidine Dimers | 2 | 1983 | 18 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 897 | 0.070 |
Why?
|
Platelet Factor 4 | 1 | 2006 | 129 | 0.070 |
Why?
|
Immunocompetence | 2 | 2018 | 137 | 0.070 |
Why?
|
TCF Transcription Factors | 1 | 2006 | 138 | 0.070 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2007 | 125 | 0.070 |
Why?
|
Thrombospondins | 1 | 2007 | 193 | 0.070 |
Why?
|
Adenine | 1 | 2012 | 976 | 0.070 |
Why?
|
Capsid Proteins | 1 | 2009 | 467 | 0.070 |
Why?
|
Radiotherapy | 1 | 2013 | 1505 | 0.070 |
Why?
|
DNA Damage | 3 | 2011 | 2442 | 0.070 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2019 | 183 | 0.060 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 84 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2015 | 8498 | 0.060 |
Why?
|
Androgen-Binding Protein | 1 | 2005 | 10 | 0.060 |
Why?
|
Taxoids | 1 | 2009 | 668 | 0.060 |
Why?
|
Albumins | 2 | 1999 | 577 | 0.060 |
Why?
|
Gene Silencing | 1 | 2012 | 1511 | 0.060 |
Why?
|
Osmosis | 1 | 2005 | 103 | 0.060 |
Why?
|
Caspase 3 | 1 | 2007 | 730 | 0.060 |
Why?
|
Injections, Intra-Arterial | 1 | 2005 | 182 | 0.060 |
Why?
|
Thrombospondin 1 | 1 | 2007 | 257 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2008 | 482 | 0.060 |
Why?
|
Software | 1 | 2019 | 4420 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2008 | 3604 | 0.060 |
Why?
|
Deoxyribonucleotides | 1 | 1984 | 43 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1094 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2007 | 2262 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 1999 | 2880 | 0.060 |
Why?
|
Chick Embryo | 1 | 2006 | 981 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 2006 | 4172 | 0.060 |
Why?
|
Injections | 3 | 2011 | 830 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2011 | 9590 | 0.060 |
Why?
|
Dependovirus | 1 | 2009 | 708 | 0.060 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2005 | 257 | 0.060 |
Why?
|
Cell Line | 6 | 2012 | 15626 | 0.060 |
Why?
|
Genes, Dominant | 1 | 2006 | 863 | 0.060 |
Why?
|
Autophagy | 1 | 2012 | 1336 | 0.060 |
Why?
|
Aotus trivirgatus | 2 | 2001 | 36 | 0.060 |
Why?
|
Genetic Engineering | 3 | 2009 | 933 | 0.060 |
Why?
|
Virus Shedding | 2 | 2001 | 111 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4024 | 0.060 |
Why?
|
Phosphorylation | 2 | 2012 | 8314 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2018 | 2730 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2014 | 18968 | 0.050 |
Why?
|
ras Proteins | 1 | 2008 | 1051 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11708 | 0.050 |
Why?
|
beta-Galactosidase | 5 | 1995 | 575 | 0.050 |
Why?
|
Base Sequence | 11 | 2006 | 12447 | 0.050 |
Why?
|
Retroviridae | 1 | 2005 | 850 | 0.050 |
Why?
|
Baclofen | 1 | 2003 | 119 | 0.050 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10183 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2024 | 190 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5644 | 0.050 |
Why?
|
Neurons | 3 | 2003 | 9416 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6545 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 8058 | 0.050 |
Why?
|
Injections, Subcutaneous | 2 | 2001 | 679 | 0.050 |
Why?
|
Polymerase Chain Reaction | 5 | 2011 | 6067 | 0.050 |
Why?
|
Consumer Product Safety | 2 | 2001 | 123 | 0.050 |
Why?
|
Drug Delivery Systems | 2 | 2005 | 2218 | 0.050 |
Why?
|
Gene Library | 2 | 2019 | 1060 | 0.050 |
Why?
|
Carcinogens | 1 | 1984 | 449 | 0.050 |
Why?
|
Neurofibromatosis 2 | 1 | 2006 | 385 | 0.050 |
Why?
|
Antigens, Differentiation | 2 | 2006 | 912 | 0.050 |
Why?
|
Microscopy, Electron | 5 | 1994 | 2558 | 0.050 |
Why?
|
Plasmids | 4 | 2006 | 2277 | 0.050 |
Why?
|
Viral Vaccines | 2 | 1999 | 598 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 2 | 1999 | 1356 | 0.050 |
Why?
|
beta Catenin | 1 | 2006 | 1043 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Cell Hypoxia | 2 | 2015 | 657 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2015 | 3483 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2007 | 9531 | 0.050 |
Why?
|
Proteins | 1 | 1996 | 6030 | 0.050 |
Why?
|
Immunotherapy, Active | 1 | 2001 | 59 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 11902 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2001 | 322 | 0.050 |
Why?
|
Prodrugs | 1 | 2002 | 259 | 0.050 |
Why?
|
Administration, Intravesical | 1 | 2000 | 92 | 0.050 |
Why?
|
Carotid Arteries | 1 | 2005 | 951 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2018 | 64947 | 0.040 |
Why?
|
Neuroendocrine Tumors | 1 | 2007 | 649 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2014 | 11480 | 0.040 |
Why?
|
Primates | 2 | 2001 | 523 | 0.040 |
Why?
|
Rectal Neoplasms | 1 | 2009 | 1151 | 0.040 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2000 | 93 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 184 | 0.040 |
Why?
|
Diterpenes | 1 | 2000 | 171 | 0.040 |
Why?
|
Capsaicin | 1 | 2000 | 231 | 0.040 |
Why?
|
Neurotoxins | 1 | 2000 | 240 | 0.040 |
Why?
|
K562 Cells | 1 | 2001 | 640 | 0.040 |
Why?
|
Pain Threshold | 1 | 2003 | 600 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2000 | 10829 | 0.040 |
Why?
|
Evans Blue | 1 | 1998 | 42 | 0.040 |
Why?
|
Time Factors | 10 | 2009 | 40133 | 0.040 |
Why?
|
Phenotype | 2 | 2011 | 16543 | 0.040 |
Why?
|
Solubility | 1 | 2001 | 1088 | 0.040 |
Why?
|
Hyperalgesia | 1 | 2003 | 530 | 0.040 |
Why?
|
Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2001 | 280 | 0.040 |
Why?
|
DNA, Bacterial | 2 | 1983 | 1455 | 0.040 |
Why?
|
Histamine | 1 | 2000 | 499 | 0.040 |
Why?
|
Kainic Acid | 1 | 1998 | 199 | 0.040 |
Why?
|
Biological Therapy | 1 | 1999 | 139 | 0.040 |
Why?
|
DNA Modification Methylases | 2 | 2011 | 208 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 151 | 0.040 |
Why?
|
Androgens | 1 | 2005 | 1289 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 2000 | 498 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4437 | 0.040 |
Why?
|
Organ Specificity | 1 | 2002 | 1955 | 0.040 |
Why?
|
Tumor Burden | 2 | 2015 | 1897 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2022 | 772 | 0.040 |
Why?
|
Medulla Oblongata | 1 | 1998 | 248 | 0.040 |
Why?
|
Haplorhini | 2 | 2001 | 529 | 0.040 |
Why?
|
Glycosylation | 1 | 2000 | 1097 | 0.040 |
Why?
|
DNA Repair Enzymes | 2 | 2011 | 345 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2020 | 482 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1998 | 514 | 0.040 |
Why?
|
Quinazolinones | 1 | 2019 | 223 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 1999 | 1628 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12959 | 0.040 |
Why?
|
Kinetics | 6 | 2011 | 6378 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4573 | 0.030 |
Why?
|
Random Allocation | 3 | 2014 | 2394 | 0.030 |
Why?
|
Locus Coeruleus | 1 | 1998 | 231 | 0.030 |
Why?
|
Thionucleotides | 1 | 1996 | 112 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2001 | 1354 | 0.030 |
Why?
|
Cell Growth Processes | 2 | 2007 | 384 | 0.030 |
Why?
|
Antibodies, Viral | 4 | 2000 | 3145 | 0.030 |
Why?
|
Lentivirus | 1 | 2019 | 505 | 0.030 |
Why?
|
Mutagenesis | 1 | 2000 | 1234 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2018 | 383 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1997 | 871 | 0.030 |
Why?
|
Genes, Reporter | 4 | 2009 | 1531 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1999 | 1765 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1998 | 908 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2022 | 12762 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2001 | 1254 | 0.030 |
Why?
|
Male | 23 | 2012 | 359413 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1996 | 778 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2006 | 17628 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1998 | 1993 | 0.030 |
Why?
|
Pruritus | 1 | 1998 | 377 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1327 | 0.030 |
Why?
|
Base Composition | 2 | 1992 | 290 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1998 | 708 | 0.030 |
Why?
|
Nociceptors | 1 | 1998 | 457 | 0.030 |
Why?
|
Skin Neoplasms | 4 | 2001 | 5797 | 0.030 |
Why?
|
Cell Movement | 1 | 2006 | 5206 | 0.030 |
Why?
|
Enkephalins | 1 | 1994 | 139 | 0.030 |
Why?
|
Digoxin | 1 | 2015 | 247 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2007 | 5120 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2009 | 2526 | 0.030 |
Why?
|
Sesquiterpenes | 1 | 1995 | 176 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1996 | 459 | 0.030 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 286 | 0.030 |
Why?
|
Cell Separation | 1 | 2019 | 1720 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 191 | 0.030 |
Why?
|
Hypothalamus | 1 | 1998 | 998 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 788 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3800 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 729 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2001 | 949 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 631 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1726 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 84 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2011 | 36247 | 0.030 |
Why?
|
Viruses | 1 | 1996 | 376 | 0.030 |
Why?
|
Rabbits | 2 | 1996 | 4773 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3525 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2012 | 248 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1997 | 1526 | 0.030 |
Why?
|
DNA Polymerase II | 2 | 1984 | 104 | 0.030 |
Why?
|
Tubulin Modulators | 1 | 2012 | 107 | 0.030 |
Why?
|
Dexamethasone | 1 | 1999 | 1928 | 0.030 |
Why?
|
Acetoxyacetylaminofluorene | 2 | 1982 | 5 | 0.030 |
Why?
|
Survival Rate | 3 | 2001 | 12806 | 0.030 |
Why?
|
Herpesviridae | 1 | 1992 | 106 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2000 | 6242 | 0.020 |
Why?
|
Baculoviridae | 1 | 1991 | 115 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.020 |
Why?
|
Protein Kinase C | 1 | 1996 | 1201 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 192 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4409 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10757 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 1999 | 1523 | 0.020 |
Why?
|
Immunization | 2 | 2010 | 1228 | 0.020 |
Why?
|
Gene Targeting | 1 | 1994 | 839 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1995 | 675 | 0.020 |
Why?
|
Brain Diseases | 1 | 2000 | 1540 | 0.020 |
Why?
|
Encephalitis | 1 | 1994 | 436 | 0.020 |
Why?
|
Behavior, Animal | 1 | 1998 | 1861 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4317 | 0.020 |
Why?
|
Protein Precursors | 1 | 1994 | 1135 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 418 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2010 | 139 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 825 | 0.020 |
Why?
|
Cell Shape | 1 | 2011 | 372 | 0.020 |
Why?
|
DNA Shuffling | 1 | 2009 | 5 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2010 | 132 | 0.020 |
Why?
|
2-Aminopurine | 1 | 2009 | 11 | 0.020 |
Why?
|
Acyclovir | 1 | 1990 | 269 | 0.020 |
Why?
|
Escherichia coli | 7 | 1988 | 4223 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7512 | 0.020 |
Why?
|
Cell Transformation, Viral | 1 | 1990 | 526 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1080 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2008 | 3160 | 0.020 |
Why?
|
Antimetabolites | 1 | 2009 | 127 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 2 | 2011 | 2804 | 0.020 |
Why?
|
Viral Tropism | 1 | 2009 | 102 | 0.020 |
Why?
|
Aotidae | 2 | 2000 | 59 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2009 | 144 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2001 | 3390 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1649 | 0.020 |
Why?
|
Brain | 4 | 2000 | 26912 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1991 | 814 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 204 | 0.020 |
Why?
|
Bacteriophage phi X 174 | 6 | 1982 | 20 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2008 | 189 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 590 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2978 | 0.020 |
Why?
|
Genes, Viral | 1 | 1988 | 650 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1843 | 0.020 |
Why?
|
Luciferases | 1 | 2009 | 716 | 0.020 |
Why?
|
Epigenomics | 1 | 2013 | 936 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1617 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2003 | 5755 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6855 | 0.020 |
Why?
|
DNA Polymerase III | 3 | 1982 | 51 | 0.020 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1988 | 367 | 0.020 |
Why?
|
Lung | 1 | 2005 | 9989 | 0.020 |
Why?
|
Comet Assay | 1 | 2006 | 74 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2011 | 13249 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2008 | 453 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 616 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1655 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2006 | 368 | 0.020 |
Why?
|
Up-Regulation | 2 | 2011 | 4127 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 181 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2006 | 402 | 0.020 |
Why?
|
Templates, Genetic | 5 | 1985 | 189 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2006 | 455 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2006 | 135 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2006 | 240 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1483 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4002 | 0.010 |
Why?
|
Guanine | 1 | 2006 | 278 | 0.010 |
Why?
|
Lac Operon | 2 | 1994 | 237 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1984 | 168 | 0.010 |
Why?
|
Manganese | 2 | 1984 | 395 | 0.010 |
Why?
|
RNA Interference | 1 | 2013 | 2846 | 0.010 |
Why?
|
Drug Implants | 1 | 2005 | 230 | 0.010 |
Why?
|
Neural Stem Cells | 1 | 2011 | 884 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2918 | 0.010 |
Why?
|
Phentolamine | 1 | 2003 | 102 | 0.010 |
Why?
|
Magnesium | 2 | 1984 | 810 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2056 | 0.010 |
Why?
|
DNA Primers | 2 | 2000 | 2819 | 0.010 |
Why?
|
Pain | 1 | 1998 | 5066 | 0.010 |
Why?
|
Fluorenes | 1 | 1984 | 157 | 0.010 |
Why?
|
Genes, p53 | 1 | 2006 | 714 | 0.010 |
Why?
|
Cell Nucleus | 2 | 1990 | 2909 | 0.010 |
Why?
|
Vigabatrin | 1 | 2003 | 88 | 0.010 |
Why?
|
Binding Sites | 1 | 1991 | 6050 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 4 | 1986 | 224 | 0.010 |
Why?
|
Heparin | 1 | 2009 | 1655 | 0.010 |
Why?
|
Drug Synergism | 1 | 2006 | 1755 | 0.010 |
Why?
|
Chromatin | 1 | 2013 | 2939 | 0.010 |
Why?
|
Temperature | 2 | 2000 | 2221 | 0.010 |
Why?
|
Mutagens | 1 | 1982 | 178 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1173 | 0.010 |
Why?
|
Organ Size | 1 | 2006 | 2249 | 0.010 |
Why?
|
Skin | 1 | 1994 | 4468 | 0.010 |
Why?
|
Radiation, Ionizing | 1 | 2001 | 251 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3758 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1980 | 112 | 0.010 |
Why?
|
Ultraviolet Rays | 2 | 1983 | 1078 | 0.010 |
Why?
|
Biological Transport | 1 | 2005 | 2087 | 0.010 |
Why?
|
Bupivacaine | 1 | 2003 | 413 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2011 | 3665 | 0.010 |
Why?
|
Tears | 1 | 2000 | 251 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6499 | 0.010 |
Why?
|
Cattle | 1 | 1984 | 3847 | 0.010 |
Why?
|
DNA, Circular | 1 | 1978 | 97 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2651 | 0.010 |
Why?
|
Immediate-Early Proteins | 1 | 2001 | 449 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2811 | 0.010 |
Why?
|
Deoxyribonucleases | 1 | 1979 | 212 | 0.010 |
Why?
|
Sciatic Nerve | 1 | 2001 | 612 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2003 | 1169 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4891 | 0.010 |
Why?
|
Neurology | 1 | 2005 | 779 | 0.010 |
Why?
|
Hot Temperature | 1 | 2003 | 1435 | 0.010 |
Why?
|
Saliva | 1 | 2000 | 816 | 0.010 |
Why?
|
United States | 1 | 2024 | 72363 | 0.010 |
Why?
|
Vagina | 1 | 2000 | 842 | 0.010 |
Why?
|
Models, Neurological | 1 | 2003 | 1758 | 0.010 |
Why?
|
GAP-43 Protein | 1 | 1994 | 152 | 0.010 |
Why?
|
Cyclohexanes | 1 | 1995 | 152 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1999 | 1529 | 0.010 |
Why?
|
Vaccines, Attenuated | 1 | 1995 | 316 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12100 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9388 | 0.010 |
Why?
|
Idoxuridine | 1 | 1994 | 111 | 0.010 |
Why?
|
Cerebellar Cortex | 1 | 1994 | 107 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1994 | 2094 | 0.010 |
Why?
|
Dentate Gyrus | 1 | 1994 | 163 | 0.010 |
Why?
|
Recurrence | 1 | 2005 | 8487 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1994 | 389 | 0.010 |
Why?
|
Medical Oncology | 1 | 2005 | 2321 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2001 | 1957 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 1992 | 144 | 0.010 |
Why?
|
Cell Transplantation | 1 | 1995 | 473 | 0.010 |
Why?
|
Prostate | 1 | 2001 | 1793 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1994 | 370 | 0.010 |
Why?
|
Virus Latency | 1 | 1995 | 362 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41317 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 1994 | 333 | 0.010 |
Why?
|
Avian myeloblastosis virus | 2 | 1982 | 20 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 852 | 0.010 |
Why?
|
Isoenzymes | 1 | 1996 | 1690 | 0.010 |
Why?
|
Virulence | 1 | 1995 | 1295 | 0.010 |
Why?
|
Hippocampus | 2 | 1994 | 3737 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1995 | 1490 | 0.010 |
Why?
|
Neurofibromatoses | 1 | 1995 | 299 | 0.010 |
Why?
|
Safety | 1 | 1995 | 1149 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1994 | 756 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1994 | 1446 | 0.010 |
Why?
|
Gene Amplification | 1 | 1994 | 1085 | 0.010 |
Why?
|
Drug Resistance | 1 | 1994 | 1617 | 0.000 |
Why?
|
Apurinic Acid | 1 | 1986 | 1 | 0.000 |
Why?
|
Alkylation | 1 | 1986 | 84 | 0.000 |
Why?
|
Middle Aged | 2 | 2015 | 220175 | 0.000 |
Why?
|
Body Weight | 1 | 1995 | 4613 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13505 | 0.000 |
Why?
|
DNA, Single-Stranded | 1 | 1985 | 360 | 0.000 |
Why?
|
Coliphages | 1 | 1982 | 120 | 0.000 |
Why?
|
Prokaryotic Cells | 1 | 1981 | 50 | 0.000 |
Why?
|
Eukaryotic Cells | 1 | 1981 | 196 | 0.000 |
Why?
|
Nucleic Acid Conformation | 1 | 1982 | 899 | 0.000 |
Why?
|
Substrate Specificity | 1 | 1982 | 1792 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2000 | 39254 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1982 | 3086 | 0.000 |
Why?
|
Molecular Weight | 1 | 1978 | 2186 | 0.000 |
Why?
|
Cricetinae | 1 | 1979 | 2427 | 0.000 |
Why?
|
Models, Biological | 1 | 1985 | 9468 | 0.000 |
Why?
|
Aged | 1 | 2000 | 168995 | 0.000 |
Why?
|
Adult | 1 | 2000 | 219847 | 0.000 |
Why?
|